Geode Capital Management LLC Boosts Stock Holdings in ImmuCell Co. (NASDAQ:ICCC)

Geode Capital Management LLC raised its position in shares of ImmuCell Co. (NASDAQ:ICCC) by 13.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 64,538 shares of the biotechnology company’s stock after acquiring an additional 7,878 shares during the quarter. Geode Capital Management LLC owned approximately 0.72% of ImmuCell worth $332,000 as of its most recent SEC filing.

Separately, Mesirow Financial Investment Management Inc. raised its position in shares of ImmuCell by 100.0% in the fourth quarter. Mesirow Financial Investment Management Inc. now owns 24,356 shares of the biotechnology company’s stock valued at $125,000 after buying an additional 12,178 shares during the last quarter. Hedge funds and other institutional investors own 13.47% of the company’s stock.

ImmuCell Stock Performance

NASDAQ:ICCC opened at $5.29 on Friday. ImmuCell Co. has a twelve month low of $3.34 and a twelve month high of $5.82. The company has a market cap of $47.58 million, a P/E ratio of -10.58 and a beta of 0.23. The company has a current ratio of 3.11, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. The company’s 50-day moving average price is $5.17 and its 200-day moving average price is $4.76.

ImmuCell (NASDAQ:ICCC) last announced its quarterly earnings data on Tuesday, February 25th. The biotechnology company reported $0.06 earnings per share (EPS) for the quarter. ImmuCell had a negative net margin of 15.99% and a negative return on equity of 15.32%. The firm had revenue of $7.75 million during the quarter.

ImmuCell Company Profile

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E.